β细胞功能障碍还是胰岛素高分泌:血糖异常发病机制中的首要事件
本综述讨论2型糖尿病发病机制中β细胞功能障碍与胰岛素高分泌何为首要事件的两种模型。文中整合临床前与临床研究及干预研究数据,认为多数数据支持早期β细胞功能缺陷是大多数2型糖尿病个体高血糖发病的更可能机制。
要点
- 肥胖与胰岛素抵抗与2型糖尿病发生相关,但高血糖发生需要β细胞功能障碍。
- 主流观点认为胰岛素抵抗背景下早期β细胞功能障碍是关键异常。
- 替代模型提出β细胞过度刺激致胰岛素高分泌,继而引起肥胖、胰岛素抵抗和β细胞耗竭。
核心结论
- 多数数据支持早期β细胞功能缺陷是大多数2型糖尿病个体高血糖发病的更可能机制。
研究设计与样本
- 综述整合临床前与临床研究数据,包括干预研究,围绕两种发病模型进行讨论。
主要发现
- 肥胖和胰岛素抵抗与2型糖尿病发生相关,且高血糖发生需要β细胞功能障碍。
- 主流观点认为胰岛素抵抗背景下病程早期出现的β细胞功能障碍是关键异常。
- 替代模型提出原发性β细胞过度刺激导致胰岛素高分泌,进而引起肥胖和胰岛素抵抗,最终导致β细胞耗竭。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity and insulin resistance are associated with the development of type 2 diabetes. It is well accepted that beta cell dysfunction is required for hyperglycaemia to occur. The prevailing view is that, in the presence of insulin resistance, beta cell dysfunction that occurs early in the course of the disease process is the critical abnormality. An alternative model has been proposed in which primary beta cell overstimulation results in insulin hypersecretion that then leads to the development of obesity and insulin resistance, and ultimately to beta cell exhaustion. In this review, data from preclinical and clinical studies, including intervention studies, are discussed in the context of these models. The preponderance of the data supports the view that an early beta cell functional defect is the more likely mechanism underlying the pathogenesis of hyperglycaemia in the majority of individuals who develop type 2 diabetes. Graphical abstract.
引用
- Esser N, Utzschneider KM, Kahn SE, et al. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. 2020. PMID: 32894311. doi:10.1007/s00125-020-05245-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。